Sabir Hemmen

Prof. Dr. Sabir Hemmen is a Professor and Group Leader at the German Center for Neurodegenerative Diseases (DZNE) in Bonn, Germany, with dual clinical leadership roles as Head of Experimental Neonatology and Senior Physician in the Department of Neonatology and Pediatric Intensive Care Medicine at University Hospitals Bonn, affiliated with the University of Bonn. His work bridges translational research and clinical neonatology to address critical challenges in newborn brain health.

His research program systematically investigates:

• Mechanisms of inflammation-sensitized experimental hypoxic-ischemic brain injury under normothermic and hypothermic conditions
• Microglial contributions to perinatal brain injury across diverse models including hypoxia-ischemia, inflammatory insults, and prematurity
• Development of clinically applicable biomarkers for predicting adverse neurodevelopmental outcomes
• Validation of novel neuroprotective therapeutic strategies through rigorous preclinical testing

Methodologically, his team employs longitudinal neurofunctional assessments combined with advanced cell-specific profiling techniques to dissect pathological pathways and identify intervention targets. The research directly informs clinical practice through close integration with the University Hospital Bonn's neonatal intensive care unit.

As DZNE Group Leader, Prof. Hemmen directs a specialized research unit focused on experimental neonatology, fostering collaborations between basic scientists and clinicians to accelerate the translation of mechanistic discoveries into improved neonatal care protocols and neuroprotective treatments.